RGS2 Gene Expression in Breast Cancer
Author Information
Author(s): Matthew J Smalley, Marjan Iravani, Maria Leao, Anita Grigoriadis, Howard Kendrick, Tim Dexter, Kerry Fenwick, Joseph L Regan, Kara Britt, Sarah McDonald, Christopher J Lord, Alan MacKay, Alan Ashworth
Primary Institution: Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research
Hypothesis
The study aims to identify differentially expressed genes in mammary epithelial cell populations and their relationship to breast cancer.
Conclusion
RGS2 is over-expressed in the majority of breast cancers, suggesting it may be a significant therapeutic target.
Supporting Evidence
- RGS2 was found to be highly expressed in myoepithelial cells.
- RGS2 expression was significantly higher in breast cancer samples compared to normal cells.
- Functional analysis showed RGS2 modulates oxytocin receptor signalling.
Takeaway
The study found that a gene called RGS2 is found in higher amounts in breast cancer cells compared to normal cells, which could help in developing new treatments.
Methodology
Gene expression microarray analysis was used to profile freshly isolated primary mouse mammary epithelial cells and confirm findings with quantitative real-time RT-PCR.
Potential Biases
Potential bias in sample selection and analysis methods could affect the results.
Limitations
The study primarily focuses on mouse models, which may not fully represent human breast cancer biology.
Participant Demographics
The study involved mouse mammary epithelial cells and human breast cancer samples.
Statistical Information
P-Value
3.77 × 10-10
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website